BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2009
View Archived Issues
AEterna Zentaris presents update on phase III study 041 of cetrorelix pamoate in BPH
Read More
Natalizumab improves quality of life in Crohn's disease patients
Read More
SP-304 well tolerated in phase I study in healthy volunteers
Read More
Long-term safety and low-dose efficacy of ropinirole PR studied in Parkinson's disease
Read More
Boehringer Ingelheim claims HIV integrase inhibitors for the treatment of HIV infection
Read More
Boehringer Ingelheim claims the discovery of novel antimigraine compounds
Read More
Long-term and other data on adalimumab in Crohn's disease analyzed
Read More
Xanodyne receives FDA approval for Zipsor
Read More
CuraGen advances to second stage of enrollment in phase I/II trial of CR011-vcMMAE
Read More
MacroGenics and Lilly complete enrollment in phase II/III trial of teplizumab in diabetes
Read More
Virax enrolls 50% of participants into South African phase I/IIa trial of VIR-201 HIV vaccine
Read More
TGen reports positive results from study of genetic markers in diabetes
Read More
Novartis presents novel farnesyl pyrophosphate synthase inhibitors for osteoporosis
Read More
FDA Arthritis Advisory Committee sets date to review Auxilium's BLA for Xiaflex
Read More
Retreatment with TRU-015 improves rheumatoid arthritis disease activity in phase IIb trial
Read More
Paladin launches Twinject Twinpack in Canada for anaphylaxis
Read More
Anti-IL-17A antibody AIN-457 induces clinical responses in rheumatoid arthritis patients
Read More
Celgene's Revlimid recommended for relapsed/refractory multiple myeloma in the U.K.
Read More
Debiopharm and Moffitt Cancer Center sign agreement for Debio-0928
Read More
SGN-35 begins phase II trial for anaplastic large cell lymphoma
Read More
Clinical hold removed from IMPACT-DCM trial of cardiac repair cells
Read More
First European launch for new Blopress Plus strengths
Read More
Anti-GM-CSF antibody MT-203 begins first phase I study
Read More
Second phase II study for HP-802-247 cell-based wound therapy
Read More
Novel angiotensin receptor blocker K-868 active against experimental diabetic nephropathy
Read More
OSI Prosidion reports development of dual DPP-IV inhibitor/GPR119 agonist
Read More
Meal-related symptoms improved with Z-338 in functional dyspepsia patients
Read More